What are some of the positive and/or negative consequences of the use of DTC marketing by pharmaceutical companies? Who is impacted by these consequences? The use of DTC marketing by pharmaceutical companies has both positive and negative consequences for the parties concerned in this issues. Positive consequences: • It is an advantage for patients because, before advertising by pharmaceutical companies, patients used to follow blindly what their doctors asked them to take as medication without really understanding it or knowing all the options available. Now, they are more informed about medications.
Annotated Bibliography: “Effective Methods of Communication amongst the Pharmaceutical Industry, the Public and All Those in Between” D'Arcy, E., & Moynihan, R. (2009). Can the relationship between doctors and drug companies ever be a healthy one?. International Journal Of Risk & Safety In Medicine, 21(4), 185-191. doi:10.3233/JRS-2009-0481 Is it ethical for a doctor to have a strong affiliation with a drug retailer? This question has raised several concerns. The relationship amongst doctors and drug corporations is the focus of extreme analysis.
The intent of these programs is to allow patients who have exhausted all other treatment options the access to experimental drugs that could potentially save their life. Interest in compassionate use exemptions is growing. According to the Wall Street Journal, participants in compassionate use programs grew from 1,000 patients nationwide in 2010 to more than 1,200 in 2012 (Dooren, 2012). Biotech companies and regulators alike have expressed some hesitancy about the compassionate use program, however. For biotech companies, expanded access means letting products out of tightly controlled environments, potentially subjecting the product to incorrect use and unknown adverse effects, which would still need to be reported to FDA.
Direct-to-consumer (DTC) marketing of pharmaceuticals has grown increasingly in the past decade. The American public views prescription drug advertising for a wide range of medical conditions, including high cholesterol, depression, allergies, and erectile dysfunction. The Federal Food and Drug Administration (FDA) regulates the content of these advertisements. Critics also have taken the position that the advertisements garner unearned trust from the public, are misleading, and promote unnecessary use of prescription drugs for common problems associated with aging. Proponents counter that DTC ads help eliminate stigmas associated with certain medical conditions, give patients an active role in their health care management, and encourages the doctor/patient relationship.
To do this, it is important to consider the ethical issues pertaining to these tactics. Numerous ethical dilemmas exist when examining the pharmaceutical industry’s tactics. This paper will serve to examine a mere few of these examples. Today’s world of medicine is dominated by industry, as physicians and patients alike rely on pharmaceutical companies to provide medications that address patient health concerns. Pharmaceutical companies intend to profit from the d... ... middle of paper ... .../147318/100,000_americans_die_each_year_from_prescription_drugs,_while_pharma_companies_get_rich>.
Preface: In the Pharmaceutical Industry an ethical dilemma has arise over the years of gift giving from the drug companies to the doctors they encounter during their drug promotion visits. The medical sales consultants influence doctors to purchase their drugs and other medical items by giving them prestigious gifts to intrigue them to choose their company over their competitors. The purpose of my studies is to analyze gift giving in the industry and determine if the action is ethical or unethical. My data was compiled between February-March 20014, and consisted of four sources, which are all website articles written by professionals in the medical field. First Bibliographic Citation: Averill, Sarah.
Over the last several years, pharmaceutical companies have launched a campaign style called Direct to Consumer Drug Advertising or known as DTCA. This campaign has led to a large increase of clinical examinations has led to a large increase in clinical examination and this makes the pharmaceutical companies happy and helps padding their pockets. Using this type of advertising, these drug companies allow details of a particular drug to spread to a potential patient and then most likely pushed by the doctor upon visit. These types of advertising campaigns are focused on trying to “enrich” the consumer (Relman p28). Even though this type of advertising campaign allows most drugs to be cheaper overall, consumers should be concerned about the ethical and psychological effect it might have because of the type of massive advertising campaign it has become.